+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer

Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer

Cancer Epidemiology, Biomarkers & Prevention 14(5): 1311-1314

We examined whether higher human papillomavirus type 16 (HPV16) viral load predicted risk of cervical intra-epithelial neoplasia 3 (CIN3) or cancer (together termed >= CIN3) within a cohort of 20,810 women followed for 10 years with cytologic screening. Semiquantitative viral load for HPV16 was measured on baseline cervicovaginal specimens using a type-specific hybridization probe test with signal amplification.

(PDF emailed within 0-6 h: $19.90)

Accession: 012544705

Download citation: RISBibTeXText

PMID: 15894692

DOI: 10.1158/1055-9965.epi-04-0799

Related references

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. Journal of the National Cancer Institute 97(14): 1072-1079, 2005

Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 360(9328): 228-229, 2002

Human papillomavirus type 16 viral load in relation to HIV infection, cervical neoplasia and cancer in Senegal. Cancer Epidemiology 38(4): 369-375, 2015

Evaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening. Journal of Lower Genital Tract Disease 21(1): 12-16, 2016

Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study. Gynecologic Oncology 148(1): 103-110, 2017

Variable risk of cervical precancer and cancer after a human papillomavirus-positive test. Obstetrics and Gynecology 117(3): 650-656, 2011

Evaluation of any or type-specific persistence of high-risk human papillomavirus for detecting cervical precancer. Journal of Clinical Microbiology 50(2): 300-306, 2012

Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population. Journal of the National Cancer Institute 104(7): 556-565, 2012

Three-year risk of cervical precancer and cancer after the detection of low-risk human papillomavirus genotypes targeted by a commercial test. Obstetrics and Gynecology 123(1): 49-56, 2014

Cervical Precancer and Cancer Risk by Human Papillomavirus Status and Cytologic Interpretation: Implications for Risk-Based Management. Cancer Epidemiology, Biomarkers and Prevention 25(12): 1595-1599, 2016

The population impact of human papillomavirus/cytology cervical cotesting at 3-year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen. Cancer 122(23): 3682-3686, 2016

Role of Human Papillomavirus DNA Load in Predicting the Long-term Risk of Cervical Cancer: A 15-Year Prospective Cohort Study in China. Journal of Infectious Diseases 219(2): 215-222, 2019

The use of viral load as a surrogate marker in predicting disease progression for patients with early invasive cervical cancer with integrated human papillomavirus type 16. American Journal of Obstetrics and Gynecology 201(1): 79.E1-7, 2009

The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States. International Journal of Cancer 135(3): 624-634, 2014

Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18. International Journal of Cancer 140(8): 1747-1756, 2017